22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3087076/0/en/Gyre-Therapeutics-Hydronidone-Met-the-Primary-Endpoint-and-Demonstrated-Statistically-Significant-Fibrosis-Regression-in-Pivotal-Phase-3-Trial-for-the-Treatment-of-CHB-associated-L.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050406/0/en/Gyre-Therapeutics-Announces-Publication-of-Protocol-for-Phase-3-Trial-Evaluating-F351-for-CHB-Associated-Liver-Fibrosis-in-Journal-of-Clinical-and-Translational-Hepatology.html
18 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/18/2900811/0/en/Gyre-Therapeutics-Announces-Publication-in-Journal-of-Gastroenterology-and-Hepatology.html